(Press-News.org) Sophia Antipolis, 6 May 2021: One in four heart attack patients have atypical symptoms such as breathing difficulties, extreme exhaustion, and abdominal pain, according to a study published today in European Heart Journal - Acute Cardiovascular Care, a journal of the European Society of Cardiology (ESC).1 Patients with atypical symptoms were less likely to receive emergency help and more likely to die within 30 days compared to those with chest pain.
"We found that atypical symptoms were most common among older people, especially women, who called a non-emergency helpline for assistance," said study author Ms. Amalie Lykkemark Møller, PhD student, Nordsjællands Hospital, Hillerød, Denmark. "This suggests that patients were unaware that their symptoms required urgent attention."
Heart attacks require fast treatment to restore blood flow and reduce mortality. Symptom recognition by patients and health staff is crucial to reduce delays. Ms. Møller said: "Little is known about how symptoms influence the actions of patients and medical services and impact survival."
The study examined the associations between initial heart attack symptoms, the medical service response and 30-day mortality. The researchers collected data on all calls to a 24-hour medical helpline and an emergency number in the Capital Region of Denmark from 2014 to 2018. At the two services the primary symptom is registered along with the response. The researchers identified adults aged 30 and over who received a heart attack diagnosis within 72 hours of the call. Patients were divided into groups according to their primary symptom.
During the five-year period, a specific primary symptom was recorded for 7,222 of 8,336 heart attacks - chest pain was the most common (72%) while 24% of patients had atypical symptoms, the most frequent being breathing problems. The prevalence of chest pain was highest among men aged 30-59 calling the emergency number and lowest among women older than 79 calling the medical helpline. Atypical symptoms were mainly found among older patients, especially women, who called the helpline.
Among heart attack patients with chest pain, 95% and 76% received an emergency dispatch from the emergency number and medical helpline, respectively. In comparison, just 62% and 17% of heart attack patients with atypical symptoms received an emergency dispatch from the emergency number and medical helpline, respectively.
The 30-day mortality rate for heart attack patients with chest pain was 5% among those who called the emergency number and 3% among those who called the helpline. Rates were higher among heart attack patients with atypical symptoms: 23% and 15% died within 30 days after calling the emergency number and helpline, respectively.
To make a more like-for-like comparison of mortality between patients with chest pain versus atypical symptoms, the researchers standardised for age, sex, education level, diabetes, previous heart attack, heart failure, and chronic obstructive pulmonary disease. The standardised 30-day mortality was 4.3% for patients with chest pain and 15.6% for those with atypical symptoms.
Ms. Møller said: "Taken together, our results show that heart attack patients with chest pain were three times more likely to receive an emergency ambulance than those with other symptoms. People with atypical symptoms more often called the helpline, which could indicate that their symptoms were milder, or they were not aware of the severity. Vague symptoms may contribute to health staff misinterpreting them as benign."
While breathing difficulties, extreme exhaustion, impaired consciousness, and abdominal pain were the most common heart attack symptoms after chest pain, Ms. Møller noted that in most cases these problems are not caused by a heart attack. "Unfortunately, people in this situation will not know the cause, but we hope our study improves awareness - particularly among older patients and health professionals - that it could be a heart attack," she said.
"Death within 30 days was more than three-fold higher in those with atypical symptoms compared to chest pain," she added. "This could be due to treatment delays caused by not receiving the appropriate emergency dispatch. However, it is unknown whether an increase in emergency dispatches alone would improve survival among heart attack patients with atypical symptoms - we aim to investigate this in future research projects."
INFORMATION:
Authors: ESC Press Office
Tel: +33 (0)4 89 87 20 85
Mobile: +33 (0)7 8531 2036
Email: press@escardio.org
Follow us on Twitter @ESCardioNews
Funding: The Danish Heart Foundation (R122-A8403).
Disclosures: Please see the paper.
Notes
References
1Møller AL, Mills EHA, Gnesin F, et al. Impact of myocardial infarction symptom presentation on emergency response and survival. Eur Heart J Acute Cardiovasc Care. 2021. doi:10.1093/ehjacc/zuab023.
Link will go live on publication:
https://academic.oup.com/ehjacc/article-lookup/doi/10.1093/ehjacc/zuab023
About the European Society of Cardiology
The European Society of Cardiology brings together health care professionals from more than 150 countries, working to advance cardiovascular medicine and help people lead longer, healthier lives.
About European Heart Journal - Acute Cardiovascular Care
European Heart Journal - Acute Cardiovascular Care publishes material on all aspects of acute cardiac care such as acute coronary syndromes, cardiogenic shock, cardiac arrest, cardiac arrhythmias and acute heart failure.
A large study from Denmark and Norway published by The BMJ today sheds more light on the risk of rare blood clots in adults receiving their first dose of the Oxford-AstraZeneca covid-19 vaccine.
The findings show slightly increased rates of vein blood clots including clots in the veins of the brain, compared with expected rates in the general population. However, the researchers stress that the risk of such adverse events is considered low.
Cases of rare blood clots in people who have recently received their first dose of the Oxford-AstraZeneca covid-19 vaccine have been reported. Whether these cases represent excess events above expected ...
The new Danish-Norwegian study is the first study to document possible adverse events in relation to the COVID-19 vaccine Vaxzevria? from AstraZeneca, in which all vaccine recipients have been followed systematically, as opposed to previous studies, which have relied primarily on reported adverse reactions.
The new study was a cooperation between Danish and Norwegian research institutions.
- In this study, we were able to identify all hospital contacts among vaccinated persons by utilising the unique Danish and Norwegian health registers. This ensures that we get a comprehensive of the rate of adverse reactions. ...
Some clinicians are concerned that post-traumatic stress disorder (PTSD) diagnosis has risen throughout Western society since the late 1980s. Is this correct? And if so, has the true incidence of PTSD really spiralled out of control, or has it simply become overdiagnosed?
Experts debate the issue in The BMJ this week.
PTSD is a serious and uncommon condition resulting from severe trauma, but it has unhelpfully become an umbrella term incorporating other disorders and normal reactions to stress, argue John Tully at the University of Nottingham and Dinesh Bhugra at King's College London's Institute for Psychiatry, Psychology & Neuroscience (IoPPN).
Estimates of lifetime population prevalence are now about 7% in the US (26 million cases) and 5% in other high income countries. ...
Admission to an intensive care unit (ICU) is associated with a small increased risk of future suicide or self-harm after discharge compared with non-ICU hospital admissions, finds a study published in The BMJ today.
The findings are particularly relevant during the covid-19 pandemic, as the number of ICU admissions around the world reach all-time highs.
The findings show that survivors of critical illness who later died by suicide or had self-harm events tended to be younger with a history of psychiatric illness, and had received invasive life support.
The researchers stress that the overall risk is still very low, but say knowledge of these factors "might allow for earlier intervention to potentially reduce this important public health problem."
Survival after ...
Israel is the first country to report national data on the Pfizer-BioNTech vaccine, with observational analysis showing that two doses provide more than 95% protection against COVID-19 infection, hospitalisation, and death, including among the elderly, at a time when the B.1.1.7 variant was the dominant strain.
A single dose of the vaccine was associated with 58% protection against infection, 76% against hospitalisation, and 77% against death, emphasising the importance of fully vaccinating adults.
Challenges to controlling the pandemic remain, including uncertainty about ...
R21/Matrix-M becomes the second malaria vaccine candidate ever to start a phase III licensure trial
This builds on the recent finding of high level efficacy of this vaccine in a phase IIb trial in children in Burkina Faso, published today in The Lancet
The first phase III trial doses were administered by the team at the Malaria Research and Training Centre, Bamako, Mali, one of five trial sites across West and East Africa
The malaria vaccine was designed at the Jenner Institute, University of Oxford, who have partnered with the Serum Institute of India for commercial development
The annual death toll from ...
A new mutation found in a gene associated with an increased risk of atrial fibrillation poses a significantly increased risk for heart failure in Black people.
The discovery, made by researchers at the University of Illinois Chicago, could change current guidelines that recommend against genetic testing in people with atrial fibrillations, also known as AFib.
"We found that this new variant confers a significantly increased risk in African Americans, and this mutation has a 50% chance of being passed on to offspring," said Dr. Dawood Darbar, UIC professor of medicine and pharmacology at the College of Medicine. "Since it increases risk for heart failure, it would be wise to test people with atrial fibrillation to see if ...
According to a new study published in the journal Research in Social and Administrative Pharmacy, hospitals that participate in the 340B Drug Pricing Program provide more medication access services -- which are services that help remove barriers to accessing necessary medications -- than comparably sized non-340B hospitals.
The University of Illinois Chicago researchers who conducted the study, which included a survey of available services sent to a nationally representative sample of hospitals across the U.S., suggest that 340B participating hospitals may be better positioned to create and administer programs that support patients who are uninsured ...
Older people with kidney disease have a higher risk of dementia, and the risk increases with the rate and stage of kidney function decline. That is according to a large observational study by researchers at Karolinska Institutet in Sweden, published in the journal Neurology. The findings stress the significance of screening and monitoring for dementia in persons with kidney disease, the researchers say.
"Our study underscores the importance of low kidney function as a possible under-recognized risk factor for dementia," says co-author Juan Jesus Carrero, professor at the Department ...
With increased media attention and political campaigns focusing on the gender pay gap, the fact that women -- on average -- are paid less than men, has become an important public discussion. While much of the focus has been on the corporate sector, a new study that looked at executive compensation at nonprofit organizations found that women earn 8.9% less than men with the gap becoming greater when there is room for salary negotiations.
The study co-authored by Curtis Hall, PhD, an associate professor in Drexel University's LeBow College of Business; Andrew R. Finley, assistant professor at the Robert Day School of Economics and Finance at Claremont McKenna College; and LeBow College of Business doctoral student Amanda R. Marino, analyzed data from IRS ...
